Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment |
| |
Authors: | A. I. Barkai S. Kowalik A. Reches |
| |
Affiliation: | (1) New York State Psychiatric Institute, Columbia University College of Physicians and Surgeons, 10032 New York, NY, USA;(2) Department of Psychiatry, Columbia University College of Physicians and Surgeons, 10032 New York, NY, USA;(3) Department of Neurology, Columbia University College of Physicians and Surgeons, 10032 New York, NY, USA |
| |
Abstract: | Levels of the dopamine metabolites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) and of the major serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA) were determined in the CSF of rats at various times after repeated electroshock treatment (EST) or chronic administration of haloperidol. The acidic metabolites were analyzed in 25 l CSF using HPLC with an electrochemical detector. A significant decrease in the CSF levels of DOPAC and HVA was found 4 days after the last administration of chronic haloperidol, EST, or both. The decrease in the level of the dopamine metabolites indicated a slower dopamine turnover, which might have resulted from hypersensitivity of presynaptic dopamine receptors after these treatments. Rats treated with haloperidol also showed an increase in 5-HIAA levels, possibly due to enhanced serotonin turnover. The 5-HIAA increase following haloperidol was prevented by a concurrent administration of EST, suggesting attenuation by EST of the haloperidol-induced enhancement of serotonin turnover. |
| |
Keywords: | Electroshock treatment Haloperidol Dopamine metabolites 5-HIAA CSF Dopamine receptors |
本文献已被 SpringerLink 等数据库收录! |
|